SEC Info - Unitedhealth Group Inc - ‘10-K’ for 12/31/11

SEC Info℠

Home

Help

Please Sign In

Unitedhealth Group Inc – ‘10-K’ for 12/31/11 – ‘EX-101.SCH’

On: Wednesday, 2/8/12, at 7:46pm ET · As of: 2/9/12 · For: 12/31/11 · Accession #: 731766-12-9 · File #: 1-10864

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/09/12  Unitedhealth Group Inc            10-K       12/31/11   99:21M

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML   1.44M 
 3: EX-21.1     Subsidiaries of the Company                         HTML    196K 
 4: EX-23.1     Consent of Independent Registered Public            HTML     32K 
                Accounting Firm                                                  
 5: EX-24.1     Power of Attorney                                   HTML     38K 
 2: EX-12.1     Computation of Ratio of Earnings to Fixed Charges   HTML     43K 
 6: EX-31.1     Certification Pursuant to Section 302 of the        HTML     46K 
                Sarbanes-Oxley Act 2002                                          
 7: EX-32.1     Certification Pursuant to Section 906 of the        HTML     35K 
                Sarbanes-Oxley Act 2002                                          
67: R1          Document and Entity Information                     HTML     59K 
54: R2          Condensed Consolidated Balance Sheets               HTML    157K 
65: R3          Consolidated Balance Sheets (Parenthetical)         HTML     66K 
70: R4          Condensed Consolidated Statements of Operations     HTML    122K 
89: R5          Condensed Consolidated Statements of Changes in     HTML    112K 
                Shareholders' Equity                                             
56: R6          Consolidated Statement of Changes in Shareholders   HTML     36K 
                equity (Parentheticals)                                          
64: R7          Condensed Consolidated Statements of Cash Flows     HTML    169K 
48: R8          Description of Business                             HTML     34K 
38: R9          Basis of Presentation                               HTML    112K 
90: R10         Investments                                         HTML    276K 
72: R11         Fair Value                                          HTML    305K 
71: R12         Property, Equipment and Capitalized Software        HTML     55K 
77: R13         Goodwill                                            HTML    123K 
78: R14         Medical Costs and Medical Costs Payable             HTML     62K 
75: R15         Commercial Paper and Long-Term Debt                 HTML    174K 
79: R16         Income Taxes                                        HTML    148K 
66: R17         Shareholders' Equity                                HTML     61K 
68: R18         Share-Based Compensation                            HTML     97K 
74: R19         Commitments and Contingencies                       HTML     66K 
99: R20         Segment Financial Information                       HTML    301K 
85: R21         Quarterly Financial Data (Unaudited)                HTML     76K 
60: R22         Schedule I                                          HTML    175K 
73: R23         Basis of Presentation (Policy)                      HTML    203K 
62: R24         Basis of Presentation Basis of Presentation         HTML     49K 
                (Tables)                                                         
29: R25         Investments (Tables)                                HTML    273K 
86: R26         Fair Value (Tables)                                 HTML    295K 
94: R27         Property, Equipment and Capitalized Software        HTML     52K 
                (Tables)                                                         
43: R28         Goodwill (Tables)                                   HTML    127K 
42: R29         Medical Costs and Medical Costs Payable Medical     HTML     59K 
                Costs And Medical Costs Payable (Tables)                         
46: R30         Commercial Paper and Long-Term Debt (Tables)        HTML    175K 
47: R31         Income Taxes Income Taxes (Tables)                  HTML    147K 
49: R32         Shareholders' Equity (Tables)                       HTML     39K 
21: R33         Share-Based Compensation (Tables)                   HTML     79K 
83: R34         Commitments and Contingencies Commitments and       HTML     42K 
                Contingencies (Tables)                                           
58: R35         Segment Financial Information (Tables)              HTML    289K 
61: R36         Quarterly Financial Data (Unaudited) Quarterly      HTML     74K 
                Financial Data (Tables)                                          
33: R37         Basis of Presentation Basis of Presentation         HTML     64K 
                (Details)                                                        
98: R38         Basis of Presentation Medicare Part D (Details)     HTML     35K 
14: R39         Basis of Presentation Useful lives for property,    HTML     35K 
                equipment and capitalized software (Details)                     
51: R40         Investments (Narrative) (Details)                   HTML     43K 
88: R41         Investments (Short-Term and Long-Term Investments)  HTML     89K 
                (Details)                                                        
31: R42         Investments (Fair Value of Mortgage-Backed          HTML     51K 
                Securities by Credit Rating Origination) (Details)               
41: R43         Investments (Amortized Cost and Fair Value of       HTML     77K 
                Available-for-Sale Debt Securities by Contractual                
                Maturity) (Details)                                              
45: R44         Investments (Amortized Cost and Fair Value of       HTML     63K 
                Held-To-Maturity Debt Securities by Contractual                  
                Maturity) (Details)                                              
55: R45         Investments (Fair Value of Available-For-Sale       HTML     64K 
                Investments with Gross Unrealized Losses by                      
                Investment Type and Length of Time That Individual               
                Securities Have Been in a Continuous Unrealized                  
                Loss Position) (Details)                                         
20: R46         Investments (Net Realized Gains) (Details)          HTML     52K 
37: R47         Fair Value (Narrative) (Details)                    HTML     49K 
16: R48         Fair Value (Financial Assets and Liabilities,       HTML     74K 
                Excluding AARP, Measured at Fair Value on a                      
                Recurring Basis) (Details)                                       
87: R49         Fair Value (Assets and Liabilities measured at      HTML     86K 
                fair value on a recurring basis) (Details)                       
30: R50         Fair Value (Summary of Fair Value and Carrying      HTML     74K 
                Value for Certain Financial Instruments for Which                
                it is Practicable to Estimate Fair Value)                        
                (Details)                                                        
84: R51         Fair Value (Reconciliation of Assets Measured at    HTML     56K 
                Fair Value on a Recurring Basis Using Level 3                    
                Inputs) (Details)                                                
34: R52         Property, Equipment and Capitalized Software        HTML     36K 
                Property, Equipment and Capitalized Software                     
                (Narrative) (Details)                                            
52: R53         Property, Equipment and Capitalized Software        HTML     60K 
                Property, Equipment and Capitalized Software table               
                (Details)                                                        
15: R54         Goodwill and Other Intangible Assets Numbers in     HTML     39K 
                narrative (Details)                                              
18: R55         Goodwill (Changes in the Carrying Amount of         HTML     67K 
                Goodwill by Reporting Segment) (Details)                         
44: R56         Goodwill and Other Intangible Assets Gross          HTML     44K 
                carrying value, accumulated amortization and net                 
                carrying value of ther intangible assets (Details)               
24: R57         Goodwill and Other Intangible Assets                HTML     41K 
                Weighted-average useful lives assigned to                        
                finite-lived intangible assets acquired in                       
                business combinations (Details)                                  
91: R58         Goodwill and Other Intangible Assets Amortization   HTML     42K 
                Expense relating to Intangible Assets (Details)                  
57: R59         Medical Costs and Medical Costs Payable Narrative   HTML     32K 
                (Details)                                                        
76: R60         Medical Costs and Medical Costs Payable Medical     HTML     58K 
                Costs And Medical Costs Payable (Details)                        
36: R61         Commercial Paper and Long-Term Debt (Narrative)     HTML     49K 
                (Details)                                                        
39: R62         Commercial Paper and Long-Term Debt (Commercial     HTML     79K 
                Paper and Long-Term Debt) (Details)                              
82: R63         Commercial Paper and Long-Term Debt Maturities of   HTML     49K 
                commercial paper and long-term debt (Details)                    
80: R64         Commercial Paper and Long-Term Debt (Summary of     HTML     42K 
                Effect of Changes in Fair Value of Fair Value                    
                Hedges) (Details)                                                
59: R65         Income Taxes Income Tax Narrative (Details)         HTML     46K 
81: R66         Income Taxes Components of the provision for        HTML     54K 
                income taxes (Details)                                           
35: R67         Income Taxes Reconciliation of the tax provision    HTML     76K 
                at the U.S. Federal Statutory Rate to the                        
                provision for income taxes (Details)                             
63: R68         Income Taxes Components of deferred income tax      HTML     98K 
                assets and liabilities (Details)                                 
93: R69         Income Taxes Reconciliation of the beginning and    HTML     50K 
                ending amount of unrecognized tax benefits                       
                (Details)                                                        
17: R70         Shareholders' Equity (Details)                      HTML     81K 
28: R71         Share-Based Compensation (Narrative) (Details)      HTML     82K 
53: R72         Share-Based Compensation (Stock Option and SAR      HTML     80K 
                Activity) (Details)                                              
23: R73         Share-Based Compensation (Share-Based Compensation  HTML     49K 
                Principal Fair Value Assumptions) (Details)                      
97: R74         Share-Based Compensation (Restricted Share          HTML     59K 
                Activity) (Details)                                              
32: R75         Commitments and Contingencies (Details)             HTML     51K 
25: R76         Commitments and Contingencies Future lease          HTML     52K 
                payments (Details)                                               
27: R77         Segment Financial Information (Narrative)           HTML     32K 
                (Details)                                                        
19: R78         Segment Financial Information (Details)             HTML    143K 
22: R79         Quarterly Financial Data (Unaudited) Quarterly      HTML     58K 
                Financial Data (Details)                                         
69: R80         Schedule I Schedule I Condensed Balance Sheet       HTML    154K 
                (Details)                                                        
26: R81         Schedule I Condensed Statements of Operations       HTML     79K 
                (Details)                                                        
92: R82         Schedule I Schedule I Condensed Statements of Cash  HTML    111K 
                Flows (Details)                                                  
50: R83         Schedule I Numbers in Narrative (Details)           HTML     33K 
95: XML         IDEA XML File -- Filing Summary                      XML    156K 
40: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   3.65M 
 8: EX-101.INS  XBRL Instance -- unh-20111231                        XML   5.58M 
10: EX-101.CAL  XBRL Calculations -- unh-20111231_cal                XML    318K 
11: EX-101.DEF  XBRL Definitions -- unh-20111231_def                 XML   1.05M 
12: EX-101.LAB  XBRL Labels -- unh-20111231_lab                      XML   2.20M 
13: EX-101.PRE  XBRL Presentations -- unh-20111231_pre               XML   1.40M 
 9: EX-101.SCH  XBRL Schema -- unh-20111231                          XSD    241K 
96: ZIP         XBRL Zipped Folder -- 0000731766-12-000009-xbrl      Zip    397K

‘EX-101.SCH’ — XBRL Schema — unh-20111231

This Exhibit is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<xsd:schema attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.uhc.com/20111231" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:unh="http://www.uhc.com/20111231" xmlns:us-types="http://fasb.org/us-types/2011-01-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsd="http://www.w3.org/2001/XMLSchema">

<xsd:import namespace="http://fasb.org/us-gaap/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-gaap-2011-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-roles/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-roles-2011-01-31.xsd"/>

<xsd:import namespace="http://fasb.org/us-types/2011-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2011/elts/us-types-2011-01-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>

<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>

<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/country/2011-01-31" schemaLocation="http://xbrl.sec.gov/country/2011/country-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/currency/2011-01-31" schemaLocation="http://xbrl.sec.gov/currency/2011/currency-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/dei/2011-01-31" schemaLocation="http://xbrl.sec.gov/dei/2011/dei-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/exch/2011-01-31" schemaLocation="http://xbrl.sec.gov/exch/2011/exch-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/invest/2011-01-31" schemaLocation="http://xbrl.sec.gov/invest/2011/invest-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/naics/2011-01-31" schemaLocation="http://xbrl.sec.gov/naics/2011/naics-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/sic/2011-01-31" schemaLocation="http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd"/>

<xsd:import namespace="http://xbrl.sec.gov/stpr/2011-01-31" schemaLocation="http://xbrl.sec.gov/stpr/2011/stpr-2011-01-31.xsd"/>

<xsd:annotation>

<xsd:appinfo>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20111231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20111231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20111231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>

<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="unh-20111231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>

<link:roleType id="BasisOfPresentation" roleURI="http://www.uhc.com/role/BasisOfPresentation">

<link:definition> 2102100 - Disclosure - Basis of Presentation </link:definition>

<link:usedOn> link:presentationLink </link:usedOn>